Exane Derivatives’s Baxter International BAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-155
Closed -$12K 800
2022
Q1
$12K Sell
155
-16
-9% -$1.34K ﹤0.01% 673
2021
Q4
$14.7K Sell
171
-44
-20% -$3.54K ﹤0.01% 584
2021
Q3
$17.3K Sell
215
-6,862
-97% -$542K ﹤0.01% 691
2021
Q2
$574K Buy
+7,077
New +$594K 0.13% 160
2021
Q1
Sell
-7,914
Closed -$635K 920
2020
Q4
$635K Buy
7,914
+4,641
+142% +$368K 0.19% 116
2020
Q3
$263K Sell
3,273
-59
-2% -$4.96K 0.08% 186
2020
Q2
$287K Buy
3,332
+3,323
+36,922% +$289K 0.08% 193
2020
Q1
$731 Hold
9
﹤0.01% 563
2019
Q4
$806 Sell
9
-7,298
-100% -$604K ﹤0.01% 562
2019
Q3
$639K Sell
7,307
-2,101
-22% -$179K 0.11% 141
2019
Q2
$770K Buy
+9,408
New +$730K 0.14% 122
2017
Q2
Sell
-17
Closed -$881 633
2017
Q1
$881 Buy
+17
New +$836 ﹤0.01% 417

Other funds holding BAX

Exane Derivatives's BAX Position: Q2 2022 in Review

Exane Derivatives sold out of Baxter International (BAX) in Q2 2022, closing a stake of 155 shares — an estimated $12K sold.

Exane Derivatives first reported a position in BAX in Q1 2017 and held it in 12 quarters. The position peaked at $770K in Q2 2019. 1,073 funds tracked by Wall St. Rank hold BAX as of Q2 2022.

  • Exane Derivatives reported no remaining Baxter International position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 155 Baxter International shares in Q2 2022, an estimated $12K.
  • Exane Derivatives first reported a position in Baxter International in Q1 2017 and held it in 12 quarters.
  • Exane Derivatives's Baxter International position peaked at $770K in Q2 2019.
  • 1,073 funds tracked by Wall St. Rank held Baxter International as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.